Katsuiku Hirokawa
Directeur/Bestuurslid bij Institute For Health &Life Science
Profiel
Katsuiku Hirokawa is currently the Representative Director at the Institute For Health & Life Science since 2006.
Prior to this, he worked as an Independent Outside Director at tella, Inc.
Actieve functies van Katsuiku Hirokawa
| Bedrijven | Functie | Begin |
|---|---|---|
| Institute For Health &Life Science | Directeur/Bestuurslid | 01-05-2006 |
Eerdere bekende functies van Katsuiku Hirokawa
| Bedrijven | Functie | Einde |
|---|---|---|
| TELLA, INC. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Institute For Health &Life Science | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
